WBC
MYGN icon

Westpac Banking Corp’s Myriad Genetics MYGN Stock Holding History

Westpac Banking Corp’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-143,600
Closed -$5.54M – 960
2014
Q3 		$5.54M Buy
143,600
+28,600
+25% +$1.07M 0.05% 301
2014
Q2 		$4.48M Sell
115,000
-40,100
-26% -$1.49M 0.04% 366
2014
Q1 		$5.3M Sell
155,100
-1,900
-1% -$58.9K 0.06% 302
2013
Q4 		$3.29M Buy
+157,000
New +$3.97M 0.04% 379
2013
Q3 		– Sell
-700
Closed -$17.8K – 963
2013
Q2 		$17.8K Buy
+700
New +$20.3K ﹤0.01% 953

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Westpac Banking Corp's MYGN Position: Q4 2014 in Review

Westpac Banking Corp sold out of Myriad Genetics (MYGN) in Q4 2014, closing a stake of 143,600 shares — an estimated $5.54M sold.

Westpac Banking Corp first reported a position in MYGN in Q2 2013 and held it in 5 quarters. The position peaked at $5.54M in Q3 2014. 272 funds tracked by Wall St. Rank hold MYGN as of Q4 2014.

  • Westpac Banking Corp reported no remaining Myriad Genetics position as of Q4 2014 after selling out during the quarter.
  • Westpac Banking Corp sold 143,600 Myriad Genetics shares in Q4 2014, an estimated $5.54M.
  • Westpac Banking Corp first reported a position in Myriad Genetics in Q2 2013 and held it in 5 quarters.
  • Westpac Banking Corp's Myriad Genetics position peaked at $5.54M in Q3 2014.
  • 272 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2014.

Based on Westpac Banking Corp's 13F filing for Q4 2014, filed 11 Feb 2015.